Dozens of leading health advocacy organizations call on Congress to double funding for women’s health research. It’s a spend they say will save lives…
Two years into the pandemic, researchers are still figuring out what’s going on inside the heads of COVID-19 survivors. From brain fog, to neurologically…
Nearly two full years into the COVID-19 pandemic, researchers are still in the process of learning what’s really going on inside the heads of…
Looking for brain fog remedies? Neurological experts offer six ways to speed up recovery from COVID-19’s neurological symptoms. Memory problems. Trouble focusing. Confusion. Mounting…
New clinical trials on memory loss interventions are currently enrolling healthy participants with key Alzhemier’s biomarkers as young as 55 years old. Tau and…
Bad news arrived recently for the constantly caffeinated: Researchers recently found evidence that drinking more than six cups of coffee a day could shrink…
While drug developers are heads down in the lab working to find medical treatments to slow the progression of Alzheimer’s, one tech company is…
UPDATE: 3 March 2024, 8:22 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Today, the experimental Eli Lilly drug donanemab received the FDA’s “breakthrough therapy designation” based on its potential to treat Alzheimer’s disease. The FDA granted…
UPDATE: 3 March 2024, 8:33 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Looking for answers about Alzheimer’s treatment Aduhelm (generic name aducanumab)? Here’s a primer on what it is, what it does, and more, according to…
Dementia advocacy groups including UsAgainstAlzheimer’s, American Heart Association, Volunteers of America, National Consumers League, American Public Health Association, Alzheimer’s Association, Trust for America’s Health…
A new approach to genome sequencing newly identifies 13 rare gene variants potentially associated with Alzheimer’s. Dr. Rudy Tanzi, vice chair of neurology and…
Acadia Pharmaceuticals said today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration regarding its supplemental New…
A new study indicates that the brain-boosting benefits of psychological resilience — including overcoming conditions like persistent loneliness — might offset harm and ultimately…